Shanghai Fosun Pharmaceutical (Group) Co Ltd Class H(HK:2196)
:2196
2196
Shanghai Fosun Pharmaceutical (Group) Co
RESEARCH TOOLSreports
Shanghai Fosun Pharmaceutical (Group) Co (2196) Balance Sheet
5 Followers
Shanghai Fosun Pharmaceutical (Group) Co Balance Sheet
Shanghai Fosun Pharmaceutical (Group) Co's total assets for Q4 2025 were ¥120.07B, an increase of 1.04% from the previous quarter. HK:2196 total liabilities were ¥58.24B for the fiscal quarter, a -0.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25
Dec 24
Dec 23
Dec 22
Dec 21
Total Assets
¥ 120.07B
¥ 117.46B
¥ 113.47B
¥ 107.16B
¥ 93.29B
Total Liabilities
¥ 58.24B
¥ 57.53B
¥ 56.85B
¥ 53.05B
¥ 44.92B
Total Equity Gross Minority
¥ 61.83B
¥ 59.93B
¥ 56.62B
¥ 54.11B
¥ 48.38B
Other Metrics
Currency in CNY
Shanghai Fosun Pharmaceutical (Group) Co Debt to Assets